Recovery Trial
World
‘Recovery Trial’ finds anti-arthritis drug reduces severe COVID-19 mortality

The trial found that Baricitinib reduces the mortality of hospitalized patients by 13%. Baricitinib inhibits the enzymes of a specific family of enzyme called the Janus Kinase (JAK) family


    All text content published on peoplesdispatch.org is the property of Peoples Dispatch and is under a Creative Commons Attribution-ShareAlike 4.0 (CC BY-SA) license.
    For license to republish any audio, video or image content, please get in touch with the Peoples Dispatch Team.
    Share on Facebook Share
    Share on Twitter Tweet
    Share on Reddit Share
    Share on Whatsapp Share
    Send email Mail
    Print this Print